关注
Shirin Ibrahim
Shirin Ibrahim
未知所在单位机构
在 atalmedial.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Finding very high lipoprotein (a): the need for routine assessment
NS Nurmohamed, Y Kaiser, PCE Schuitema, S Ibrahim, M Nierman, ...
European journal of preventive cardiology 29 (5), 769-776, 2022
392022
Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods
S Ibrahim, LF Reeskamp, ESG Stroes, GF Watts
Current opinion in lipidology 31 (6), 347-355, 2020
262020
Use of lipoprotein (a) to improve diagnosis and management in clinical familial hypercholesterolemia
TR Tromp, S Ibrahim, NS Nurmohamed, J Peter, L Zuurbier, JC Defesche, ...
Atherosclerosis 365, 27-33, 2023
122023
Electronic health records to facilitate continuous detection of familial hypercholesterolemia
S Pepplinkhuizen, S Ibrahim, R Vink, B Groot, ESG Stroes, WA Bax, ...
Atherosclerosis 310, 83-87, 2020
122020
Beyond the usual suspects: expanding on mutations and detection for familial hypercholesterolemia
S Ibrahim, JC Defesche, JJP Kastelein
Expert review of molecular diagnostics 21 (9), 887-895, 2021
112021
Concordance of a high lipoprotein (a) concentration among relatives
LF Reeskamp, TR Tromp, AP Patel, S Ibrahim, M Trinder, S Haidermota, ...
JAMA cardiology 8 (12), 1111-1118, 2023
82023
Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia
S Ibrahim, LF Reeskamp, JN de Goeij, GK Hovingh, RN Planken, WA Bax, ...
European journal of preventive cardiology 31 (7), 892-900, 2024
42024
Unexpected gaps in knowledge of familial hypercholesterolaemia among Dutch general practitioners
S Ibrahim, JN de Goeij, NS Nurmohamed, J Pang, SE van den Bosch, ...
Netherlands heart journal 32 (5), 213-220, 2024
22024
Polygenic background modifies risk of coronary artery disease among individuals with heterozygous familial hypercholesterolemia
LF Reeskamp, I Shim, JS Dron, S Ibrahim, TR Tromp, AC Fahed, AP Patel, ...
JACC: Advances 2 (9), 100662, 2023
22023
LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia
S Ibrahim, ML Hartgers, LF Reeskamp, L Zuurbier, J Defesche, ...
Atherosclerosis, 117610, 2024
12024
Association Between Self‐Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension
S Ibrahim, NS Nurmohamed, D Collard, A de Weger, GK Hovingh, ...
Journal of the American Heart Association 12 (22), e031418, 2023
12023
Low-cost high-throughput genotyping for diagnosing familial hypercholesterolemia
S Ibrahim, J Van Rooij, AJMH Verkerk, J De Vries, L Zuurbier, J Defesche, ...
Circulation: Genomic and Precision Medicine 16 (5), 462-469, 2023
12023
Lifetime exposure to high LDL cholesterol in familial hypercholesterolemia causes coronary atherosclerosis in young adults: The cheetah trial
S Ibrahim, J De Goeij, L Reeskamp, RN Planken, GK Hovingh, J Min, ...
Atherosclerosis 379, S54, 2023
12023
One-item adherence questionnaire correlates with on-treatment blood pressure and ldl cholesterol levels in high risk hypertensive patients over time
S Ibrahim, NS Nurmohamed, D Collard, A Weger, R Reeskamp, ...
Journal of the American College of Cardiology 81 (8_Supplement), 1828-1828, 2023
12023
Therapy of Elevated Lipoprotein (a)
S Ibrahim, ESG Stroes
Lipoprotein (a), 347-357, 2023
12023
Familial hypercholesterolemia care by Dutch pediatricians—mind the gaps
SE van den Bosch, BA Hutten, S Ibrahim, A Wiegman, J Pang, GF Watts, ...
European Journal of Pediatrics, 1-7, 2024
2024
Enhanced identification of familial hypercholesterolemia using central laboratory algorithms
S Ibrahim, NS Nurmohamed, MC Nierman, JN de Goeij, L Zuurbier, ...
Atherosclerosis 393, 117548, 2024
2024
Decreased LDL-Cholesterol Exposure Following ANGPTL3 Inhibition Reduces Coronary Plaque Development in Homozygous Familial Hypercholesterolemia
WAM Schonck, MD Reijman, A Wiegman, S Ibrahim, WE Corpeleijn, ...
JACC. Cardiovascular imaging, S1936-878X (24) 00194-3, 2024
2024
Familial hypercholesterolemia: Novel strategies to improve detection and treatment
S Ibrahim
2024
Type 2 Diabetic Patients Have Increased Coronary Plaque Burden and Plaque Progression During 10-Year Serial Coronary CT Angiography Follow-Up
EL Gaillard, NS Nurmohamed, MJ Bom, RJ de Groot, S Ibrahim, JK Min, ...
Circulation 148 (Suppl_1), A18480-A18480, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20